Duchenne myasthenia gravis is a neurological disease caused by neuromuscular transmission disorders. Symptoms of myasthenia gravis are often muscle weakness, difficulty swallowing, difficulty breathing. If not detected and treated promptly, it can lead to respiratory failure, which is life-threatening.

Myasthenia gravis is one of the autoimmune neuromuscular diseases that is more common in women. When suffering from this disease, the patient will encounter the problem of reducing the number of acetylcholine receptors at the motor endplate due to the attack of autoimmune antibodies on these receptors. If myasthenia gravis is not treated promptly, the risk of dangerous complications will be very high.

Myasthenia gravis is a rare disease, a disorder of neuromuscular transmission, causing many dangerous complications such as drooping eyelids, difficulty swallowing, difficulty breathing, ... even death. Currently, the treatment of the disease is still facing many difficulties.

Myasthenia gravis (MG) is a highly treatable disease with many effective treatments and a natural history that continues to improve with better diagnostic tests and effective medications. Diagnosing and treating patients with MG can be very rewarding for any neurologist because most patients can live normal lives with appropriate treatment.

Childhood muscular dystrophy is a genetic disease associated with a number of gene mutations. Diseases with a genetic factor play a decisive role, the age of onset is usually quite young, mostly occurring in school-age children and some cases occurring in newborns.

Myasthenia gravis is an autoimmune neuromuscular disease that causes fluctuating weakness of the eyes, medulla, and limbs and can, in 15% of cases, cause myasthenic crisis, a neurological emergency characterized by respiratory failure. Although uncommon, myasthenia gravis requires prompt diagnosis and treatment because the potential for improvement and remission is high. In particular, the diagnosis and treatment of myasthenia gravis in pregnant women and children require special considerations.

Myasthenia gravis is a rare autoimmune disease but leaves extremely dangerous complications. Therefore, early recognition of the signs will make treatment easier, minimizing complications that occur to the human body.

Myasthenia gravis is an autoimmune disease that affects the neuromuscular system and has a variety of characteristic symptoms. The primary cause is thought to be a loss of communication between the nerves and muscles, leading to decreased muscle tone.

Myasthenia gravis is an autoimmune neuromuscular disease that often begins silently, with typical symptoms such as drooping eyelids, strabismus, headache, difficulty speaking and swallowing, etc. The disease can cause coma and even death if not treated promptly. The risk of death from myasthenia gravis is mainly due to respiratory complications.

Myasthenia gravis is an autoimmune disease that affects the neuromuscular system, leading to muscle weakness or wasting. Current treatments for myasthenia gravis aim to relieve symptoms and slow the progression of the disease, but cannot cure it.

“Myasthenia gravis” is an autoimmune disease, usually accompanied by abnormalities in the thymus gland. If the body has symptoms of myasthenia gravis, it will produce a type of autoantibody against Ach, causing the amount of this substance in the body to decrease, and at the same time reducing the response of Ach receptors at the synaptic membrane.